MeiraGTx Quarterly Cash Flow Statement
NASDAQ: MGTXHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
MeiraGTx free cash flow
In the quarter ended Jun 30, 2026, MeiraGTx generated -$38.5 million of operating cash flow and spent $332,000 on capital expenditures. That left free cash flow of -$38.9 million, a free-cash-flow margin of -12.1% of revenue.
Summary generated from market data by MetaCap's automated system. Methodology
MeiraGTx cash flow statement (quarterly)
| Quarter (USD) | Q2 20262026-06-30 | Q1 20262026-03-31 | Q4 20252025-12-31 | Q3 20252025-09-30 | Q2 20252025-06-30 | Q1 20252025-03-31 | Q4 20242024-12-31 | Q3 20242024-09-30 | Q2 20242024-06-30 | Q1 20242024-03-31 | Q4 20232023-12-31 | Q3 20232023-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | 160.67M | -46.31M | 15.09M | -50.51M | -38.80M | -39.98M | -39.40M | -39.33M | -48.62M | -20.44M | 20.21M | -44.30M |
| Net Income growth (YoY) | — | — | — | — | — | — | -294.90% | — | — | — | — | — |
| Depreciation & Amortization | 2.82M | 3.01M | 3.12M | 3.15M | 3.19M | 3.08M | 3.07M | 3.26M | 3.22M | 3.27M | 3.91M | 3.48M |
| Stock-Based Compensation | 3.78M | 3.65M | 5.60M | 5.95M | 5.66M | 4.89M | 6.12M | 6.30M | 5.81M | 6.96M | 6.96M | 7.05M |
| Change in Working Capital | -10.24M | -2.04M | -1.25M | 9.90M | -10.31M | -6.97M | 8.90M | 13.26M | -163.00K | 1.44M | 14.94M | -9.46M |
| Operating Cash Flow | -38.54M | 17.81M | 46.63M | -12.21M | -43.95M | -36.83M | -23.28M | -25.02M | -19.46M | -36.74M | -14.55M | -24.41M |
| Capital Expenditures | -332.00K | -2.01M | -272.00K | -610.00K | -1.23M | -1.71M | -1.22M | -730.00K | -1.33M | -1.68M | -3.03M | -3.56M |
| Investing Cash Flow | -23.64M | -2.26M | -1.09M | -547.00K | -761.00K | -1.71M | -1.22M | -1.31M | -1.33M | 27.34M | 51.18M | -3.56M |
| Share Repurchases | 0 | -18.19M | — | — | — | — | — | — | — | — | — | — |
| Financing Cash Flow | 133.90M | -10.11M | 5.33M | -219.00K | 5.45M | 1.71M | 4.24M | 49.96M | 1.60M | -1.27M | 27.71M | -404.00K |
| Net Change in Cash | 71.72M | 5.44M | 50.87M | -12.98M | -39.26M | -36.83M | -20.25M | 23.62M | -19.18M | -10.67M | 64.34M | -28.38M |
| Free Cash Flow | -38.87M | 15.80M | 46.36M | -12.82M | -45.18M | -38.54M | -24.49M | -25.75M | -20.79M | -38.42M | -17.58M | -27.98M |
This table shows 12 quarterly periods of MeiraGTx's cash flow statement, from Q2 2026 back to Q3 2023, across 11 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow MGTX's reporting calendar. What is a cash flow statement?